Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Paul Tudor Jones Is Trading LyondellBasell Industries NV (LYB), Baxter International Inc. (BAX) & Merck & Co., Inc. (MRK)

Paul Tudor Jones is the manager of Tudor Investment Corp, focusing on equity, debt, venture capital, currency and the commodity markets. While PTJ isn’t known as a long-term investor, per say, we’ll still take a look at his top five equity picks from the past quarter; it’s worth it to track the best investors because of their market-beating potential.

TUDOR INVESTMENT CORPIn this way, in the latest round of 13F filings, Paul Tudor Jones’ hedge fund disclosed its largest stake was in LyondellBasell Industries NV (NYSE:LYB). The position involves 1.14 million shares and is worth $75.6 million. During the second quarter of the year, Tudor Investment Corp’s stake in LyondellBasell Industries NV (NYSE:LYB) surged by 1.13 million shares. The stock of LyondellBasell Industries NV (NYSE:LYBreturned almost 22% since the beginning of the year, while its forward P/E and PEG ratios amounting to 9.8x and 1.2 respectively.

The next two positions on our list are held by Baxter International Inc. (NYSE:BAX) and Merck & Co., Inc. (NYSE:MRK), in which the hedge fund disclosed ownership of 383,300 and 458,100 shares respectively. The value of the Tudor’s stake in Baxter International Inc. (NYSE:BAX) amounts to $26.6 million, with the hedge fund adding 380,400 shares during the last quarter. Merck & Co., Inc. (NYSE:MRK)’s stake in Tudor’s equity portfolio is worth $21.3 million, rising by 172,800 shares over the quarter. The stocks of both Baxter International Inc. (NYSE:BAX) and Merck & Co., Inc. (NYSE:MRKhave positive returns since the beginning of the year, amounting to 10.2% and 18.6% respectively.

Fourth place is held by WellPoint, Inc. (NYSE:WLP). Tudor Investment Corp disclosed ownership of 254,100 shares of the company, worth $20.8 million. In the previous round of 13F filings, the hedge fund’s position in WellPoint, Inc. (NYSE:WLP) involved 330,550 shares, and was worth $21.9 million. In addition to Tudor Investment Corp, we can mention Donald Yacktman’s Yacktman Asset Management and Cliff Asness’ Aqr Capital Management among other hedge funds that are long WellPoint, Inc. (NYSE:WLP).

The fifth position is represented by 1.4 million shares in Activision Blizzard, Inc. (NASDAQ:ATVI), disclosed by the hedge fund in its latest 13F. The value of the stake is $20 million. During the second quarter of the year, Tudor’s stake in Activision Blizzard, Inc. (NASDAQ:ATVI) increased by 1.4 million. With a forward P/E of 13.5x and a PEG of 1.0, the stock of Activision Blizzard, Inc. (NASDAQ:ATVI) has a year-to-date return of over 64%.

On the whole, the equity portfolio of Tudor Investment Corp has a market value of $1.3 billion, remaining almost flat compared with the Q1 value.

Recommended reading: Billionaire Michael Price Is Bulking Up On Intel & Hess

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!